This post in the Center for Global Health Policy’s “Science Speaks” blog examines the use of stavudine, “also known as d4T, an antiretroviral treatment that was dropped in wealthy countries years ago and that the World Health Organization has recommended stop being included in treatment programs,” to treat HIV in Malawi. “[W]hile children and pregnant or breastfeeding women, as well as tuberculosis patients have access to less toxic treatments, stavudine continues to be the first treatment supplied to most Malawi patients under the terms of the country’s grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria,” the blog writes, adding, “In a letter [.pdf] to Global Fund General Manager Gabriel Jaramillo and [U.S. Global AIDS Coordinator Ambassador] Eric Goosby, the Centre for Development of People (CEDEP), Health GAP (Global Access Project), and the Malawi Network of People Living with HIV/AIDS (MANET+) are asking the Global Fund to find a way to switch to first line treatment in Malawi that is acceptable to patients and World Health Organization standards” (8/15).
Aidspan, an independent watchdog of the Global Fund, on Wednesday published Issue 192 of its “Global Fund Observer.” The issue features an article examining new reports released by the Office of the Inspector General on three audits and four diagnostic reviews; an article highlighting two reports on the impact of the cancellation of Round 11 by the Global Fund; and an article discussing the reaction to Spain’s Global Fund contribution, among others (8/15).
“Health ministers from Swaziland and South Africa have agreed to radically change the diagnosis and treatment of the co-epidemic of [tuberculosis (TB)]/HIV in their countries,” VOA News reports. “The initiative to bring about a more vigorous response to deal with TB/HIV and [multidrug-resistant tuberculosis (MDR-TB)] is being funded by the…
The Financial Times has published a special report (.pdf), titled “Combating Tuberculosis 2013,” as World TB Day on March 24 approaches. The following summaries briefly describe the articles in the series. TB: Austerity poses risk to funding for battle ahead: The article reviews funding for efforts to fight the disease, as…
Also In Global Health News: Global Fund Audit; Indonesia’s Health System; Bread For The World Founder Profiled
A UNAIDS report released Tuesday at the 9th International Congress on AIDS in Asia and the Pacific (ICAAP) in Bali, Indonesia, estimates that more than 90 percent of the 1.7 million HIV-positive women living in Asia were infected by husbands or long-term partners who engaged in “high-risk sexual behaviours,” Agence France-Presse reports.
New research has found that drug-resistant strains of tuberculosis are just as likely to be transmitted between people as drug-sensitive TB, which could make drug-resistant forms of the disease “highly prevalent in the next few decades,” the Australian Associated Press/Sydney Morning Herald reports (Rose, 8/11).
Also In Global Health News: Global Fund, Indonesia TB Agreement; Smoking In China; ARVs In Uganda; Pediatric HIV Care In Rwanda
Indonesia To Receive $18M From Global Fund For TB Programs At the 9th International Conference on AIDS in Asia and the Pacific, an Indonesian health ministry official signed an agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria’s executive director worth $18 million that will fund TB control…
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Friday awarded Zimbabwe $37.9 million to help fight the three diseases, handing the money “directly to the new unity government” in an “unusual move,” the Associated Press reports.
Reuters examines Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine’s recent comments on the sidelines of the 9th International Conference on AIDS in Asia and the Pacific (ICAAP), that some emerging nations should consider becoming donor nations.